FAKTOR OPTIONSSCHEIN - MERCK & CO. | Market Closed - BOERSE MUENCHEN 02:26:34 2024-06-21 pm EDT | ||
| 2.069 EUR | -0.67% |
|
| Current month | +35.97% | ||
| 1 month | -12.44% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 24-06-21 | 2.069 | -0.67% |
| 24-06-20 | 2.083 | +16.30% |
| 24-06-19 | 1.791 | -3.24% |
| 24-06-18 | 1.851 | +3.35% |
| 24-06-17 | 1.791 | -6.82% |
Real-time BOERSE MUENCHEN
Last update June 21, 2024 at 02:26 pm EDT
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GK4SRM |
| ISIN | DE000GK4SRM2 |
| Date issued | 2022-05-13 |
| Strike | 113.5 $ |
| Maturity | Unlimited |
| Parity | 7.54 : 1 |
| Emission price | 3.06 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 8.01 € |
|---|---|
| Lowest since issue | 0.465 € |
| Spread | 0.01 € |
| Spread % | 0.48% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.7
USD
Average target price
142.7
USD
Spread / Average Target
+9.15%
- Stock Market
- Certificates
- Certificat
